Xponential Fitness Inc. (NYSE:XPOF) faces lower UBS forecasts and a $4.50 price target, down from $7, after weaker sales prompted management to cut guidance. Management's revised guidance puts financial year 2026 revenue at $250 million to $260 million and EBITDA at $91 million to $97 million.








